Company: DMAAR
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001213900-25-026240
Chunk: 806

Company: Drugs Made In America Acquisition Corp.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 9A
Chunk 806
---
 advisors to assist with the evaluation and will obtain an opinion from
an independent investment banking firm or an independent accounting firm that our initial business combination is fair to our company
from a financial point of view.

Director Independence

The Nasdaq listing rules require that a majority
of our board of directors be independent within one year of our initial public offering. An “independent director” is defined
generally as a person that, in the opinion of the company’s board of directors, has no material relationship with the listed company
(either directly or as a partner, shareholder or officer of an organization that has a relationship with the company). We have three “independent
directors” as defined in the Nasdaq rules and applicable SEC rules. Our board has determined that each of Catherine Do, G. Sridhar
Prasad and Myron W. Shulgan is an independent director under applicable SEC and Nasdaq rules. Our independent directors will have regularly
scheduled meetings at which only independent directors are present.

ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES.

The firm of MaloneBailey, LLP (“MaloneBailey”),
acts as our independent registered public accounting firm. The following is a summary of fees paid to MaloneBailey for services rendered.

Audit Fees. During the period from May
23, 2024 (inception) through December 31, 2024, fees for our independent registered public accounting firm were approximately $151,880
for the services MaloneBailey performed in connection with our Initial Public Offering and the audit of our December 31, 2024 financial
statements included in this Annual Report on Form 10-K.

Audit-Related Fees. During the period from
May 23, 2024 (inception) through December 31, 2024, our independent registered public accounting firm did not render assurance and related
services related to the performance of the audit or review of financial statements.

Tax Fees. During the period from May 23,
2024 (inception) through December 31, 2024, our independent registered public accounting firm did not render services to us for tax compliance,
tax advice and tax planning.

All Other Fees. During the period from
May 23, 2024 (inception) through December 31, 2024, there were no fees billed for products and services provided by our independent registered
public accounting firm other than those set forth above.

Pre-Approval Policy

Our audit committee was formed upon